Trials / Conditions / Familial Hypercholesterolemia - Heterozygous

Familial Hypercholesterolemia - Heterozygous

8 registered clinical trials studyying Familial Hypercholesterolemia - Heterozygous — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcib NCT07102511	LIB Therapeutics LLC	Phase 3
Recruiting	Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemi NCT06597019	Novartis Pharmaceuticals	Phase 3
Unknown	Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia NCT05218005	University of British Columbia	N/A
Completed	Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterol NCT04652726	Novartis Pharmaceuticals	Phase 3
Active Not Recruiting	Genetic Testing and Motivational Counseling for FH NCT04656028	National Medical Research Center for Therapy and Preventive Medicine	N/A
Completed	Study of Coronary Calcification in Subjects With Autosomal Dominant Familial Hypercholesterolemia Heterozygous NCT03501875	Assistance Publique - Hôpitaux de Paris	N/A
Unknown	MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR) NCT02517944	Institute of Cardiometabolism and Nutrition, France	—
Recruiting	Early Detection of Familial Hypercholesterolemia in Children NCT04370899	Institut Investigacio Sanitaria Pere Virgili	—